Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Merck Access Program for PREVYMIS™ (letermovir)
Learn how The Merck Access Program for PREVYMIS™ (letermovir) can help eligible patients.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for merckaccessprogram-prevymis.com: 13.249.39.42, 13.249.39.59, 13.249.39.103, 13.249.39.120. Moreover, DNS used with this website include ns-1422.awsdns-49.org, ns-1869.awsdns-41.co.uk, ns-305.awsdns-38.com, ns-727.awsdns-26.net. Subnet identifier ranges from 13.249.0.0 to 13.249.255.255. Classless Inter-Domain Routing (CIDR) is 13.249.0.0/16. ARIN net type is Reallocated.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns-1422.awsdns-49.org
ns-1869.awsdns-41.co.uk
ns-305.awsdns-38.com
ns-727.awsdns-26.net
{{value}}
2017-07-18
2023-07-18
MarkMonitor Inc.
{{value}}
The registrar of merckaccessprogram-prevymis.com is MarkMonitor Inc. and the name expires on 2023-07-18. According to open source data, you can reach the owner at merckdomains@merck.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
133
N/A
N/A
633.2K
133
991.3K
N/A